Company Analysis

Elutia Inc. (ELUT)

Nasdaq: ELUT · Biological Products, (No Diagnostic Substances) · Silver Spring, MD · filing with the SEC since 2017
Grade4.7
◀ Past 3.2● Present 5.1▶ Future 5.2
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

3 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Elutia Inc.’s names, not what it holds today.

Patents granted
3
3 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against 1 in 2024 and none in 2023
Applications published
4
2 of them in 2025
Names they are printed under
4
a subsidiary, a former name, its own name
By yearGrantedApplications published
'18'19'21'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology1
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Elutia Med LLC a subsidiary
US, as the owner printed on each patent
1 granted
2 published
AZIYO BIOLOGICS INC. a former name
named as the applicant on its applications, in US
0 granted
2 published
Aziyo Biologics, Inc. a former name
US, as the owner printed on each patent
1 granted
0 published
ELUTIA INC. its own name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Mar 11, 202512,247,225Placental tissue compositions and methodsPharmaceuticalsELUTIA INC.
Dec 17, 202412,168,084Extracellular matrix (ECM) structures for tissue regenerationMedical technologyElutia Med LLC
Feb 13, 20189,888,999Acellular dermal allografts and method of preparationMedical technologyAziyo Biologics, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jul 17, 20252025/0228999EXTRACELLULAR MATRIX SHEET STRUCTURESMedical technologyElutia Med LLC
Feb 13, 20252025/0049990ENCASEMENT STRUCTURES FOR IMPLANTABLE DEVICESMedical technologyElutia Med LLC
Sep 2, 20212021/0269775PLACENTAL TISSUE COMPOSITIONS AND METHODSPharmaceuticalsAZIYO BIOLOGICS INC. · patent 12,247,225 granted from it
Dec 5, 20192019/0365948LYOPHILIZED PLACENTAL COMPOSITE SHEET AND USES THEREOFMedical technologyAZIYO BIOLOGICS INC.
What it applied for, 2024 to 2025: Medical technology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ELUT · research, not advice